Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact

Issue published February 8, 2024

  • Volume 9, Issue 3
  • Previous Issue | Next Issue
Go to section:
  • Perspective
  • Research Articles
  • Corrigenda
Blocking IL-6 signaling prevents astrocyte-induced neurodegeneration in an iPSC-based model of Parkinson’s disease

Pons et al. report that glial-related neuroinflammatory responses are key components of Parkinson’s disease physiopathology. The cover art depicts Parkinson’s disease astrocytes releasing the proinflammatory cytokine IL-6 (red), which binds to specific receptors expressed on the surface of target cells (neurons). Image credit: Ella Maru Studio (@Ella_Maru).

Perspective
Sociodemographic factors and research experience impact MD-PhD program acceptance
Darnell K. Adrian Williams, … , Dania Daye, Myles H. Akabas
Darnell K. Adrian Williams, … , Dania Daye, Myles H. Akabas
Published February 8, 2024
Citation Information: JCI Insight. 2024;9(3):e176146. https://doi.org/10.1172/jci.insight.176146.
View: Text | PDF
Article has an altmetric score of 67

Sociodemographic factors and research experience impact MD-PhD program acceptance

  • Text
  • PDF
Abstract

The 2014 NIH Physician-Scientist Workforce Working Group predicted a future shortage of physician-scientists. Subsequent studies have highlighted disparities in MD-PhD admissions based on race, income, and education. Our analysis of data from the Association of American Medical Colleges covering 2014–2021 (15,156 applicants and 6,840 acceptees) revealed that acceptance into US MD-PhD programs correlates with research experience, family income, and research publications. The number of research experiences associated with parental education and family income. Applicants were more likely to be accepted with a family income greater than $50,000 or with one or more publications or presentations. Applicants were less likely to be accepted if they had parents without a graduate degree, were Black/African American, were first-generation college students, or were reapplicants, irrespective of the number of research experiences, publications, or presentations. These findings underscore an admissions bias that favors candidates from affluent and highly educated families, while disadvantaging underrepresented minorities.

Authors

Darnell K. Adrian Williams, Briana Christophers, Timothy Keyes, Rachit Kumar, Michael C. Granovetter, Alexandria Adigun, Justin Olivera, Jehron Pura-Bryant, Chynna Smith, Chiemeka Okafor, Mahlet Shibre, Dania Daye, Myles H. Akabas

×
Research Articles
hsa-miR-548v controls the viscoelastic properties of human cardiomyocytes and improves their relaxation rates
Eva Vermersch, … , Pascal Berson, Jean-Sébastien Hulot
Eva Vermersch, … , Pascal Berson, Jean-Sébastien Hulot
Published January 2, 2024
Citation Information: JCI Insight. 2024;9(3):e161356. https://doi.org/10.1172/jci.insight.161356.
View: Text | PDF
Article has an altmetric score of 3

hsa-miR-548v controls the viscoelastic properties of human cardiomyocytes and improves their relaxation rates

  • Text
  • PDF
Abstract

The impairment of left ventricular (LV) diastolic function with an inadequate increase in myocardial relaxation velocity directly results in lower LV compliance, increased LV filling pressures, and heart failure symptoms. The development of agents facilitating the relaxation of human cardiomyocytes requires a better understanding of the underlying regulatory mechanisms. We performed a high-content microscopy-based screening in human induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs) using a library of 2,565 human miRNA mimics and measured relaxation kinetics via high-computing analyses of motion movies. We identified hsa-miR-548v, a primate-specific miRNA, as the miRNA producing the largest increase in relaxation velocities. This positive lusitropic effect was reproduced in engineered cardiac tissues generated with healthy and BRAF T599R mutant hiPSC-CMs and was independent of changes in calcium transients. Consistent with improvements in viscoelastic responses to mechanical stretch, RNA-Seq showed that hsa-miR-548v downregulated multiple targets, especially components of the mechanosensing machinery. The exogenous administration of hsa-miR-548v in hiPSC-CMs notably resulted in a significant reduction of ANKRD1/CARP1 expression and localization at the sarcomeric I-band. This study suggests that the sarcomere I-band is a critical control center regulating the ability of cardiomyocytes to relax and is a target for improving relaxation and diastolic dysfunction.

Authors

Eva Vermersch, Salomé Neuvendel, Charlène Jouve, Andrea Ruiz-Velasco, Céline Pereira, Magali Seguret, Marie-Elodie Cattin-Messaoudi, Sofia Lotfi, Thierry Dorval, Pascal Berson, Jean-Sébastien Hulot

×

Essential role of obscurin kinase-1 in cardiomyocyte coupling via N-cadherin phosphorylation
Li Wang, … , Nathan Wright, Aikaterini Kontrogianni-Konstantopoulos
Li Wang, … , Nathan Wright, Aikaterini Kontrogianni-Konstantopoulos
Published December 21, 2023
Citation Information: JCI Insight. 2024;9(3):e162178. https://doi.org/10.1172/jci.insight.162178.
View: Text | PDF
Article has an altmetric score of 1

Essential role of obscurin kinase-1 in cardiomyocyte coupling via N-cadherin phosphorylation

  • Text
  • PDF
Abstract

Obscurins are giant cytoskeletal proteins with structural and regulatory roles. Obscurin-B (~870 kDa), the largest known isoform, contains 2 enzymatically active Ser/Thr kinase (kin) domains, kin1 and kin2, which belong to the myosin light chain kinase family. Kin1 binds to and phosphorylates N-cadherin, a major component of the intercalated disc, the unique sarcolemmal microdomain that mediates the mechanochemical coupling of adjacent cardiomyocytes. Obscurin-B containing kin1 and N-cadherin colocalize at cell junctions in embryonic rat ventricular myocytes (ERVMs), and their codistribution is regulated by Ca2+. Phosphoproteomics analysis revealed that obscurin-kin1 phosphorylates N-cadherin at Ser-788 located within the juxtamembrane region of its cytoplasmic domain, with an apparent Kcat of approximately 5.05 min–1. Overexpression of obscurin-kin1 or phosphomimic-Ser-788-Glu N-cadherin in ERVMs markedly increases cell adhesion and chemical coupling. Importantly, phosphomimic Ser-788-Glu N-cadherin exhibits significantly reduced binding to p120-catenin, while overexpression of phosphoablated Ser-788-Ala N-cadherin increases RhoA activity. Consistent with an essential role of the obscurin-kin1/N-cadherin axis in cardiomyocyte coupling, it is deregulated in end-stage human heart failure. Given the nearly ubiquitous expression of obscurin and N-cadherin, our findings may have broad applicability in deciphering the obscurin-kin1/N-cadherin axis that likely mediates cell coupling in diverse tissues and organs.

Authors

Li Wang, Panagiotis Tsakiroglou, Rex Gonzales, Suhan Cho, Amy Li, Cristobal dos Remedios, Nathan Wright, Aikaterini Kontrogianni-Konstantopoulos

×

Blocking IL-6 signaling prevents astrocyte-induced neurodegeneration in an iPSC-based model of Parkinson’s disease
Meritxell Pons-Espinal, … , Angel Raya, Antonella Consiglio
Meritxell Pons-Espinal, … , Angel Raya, Antonella Consiglio
Published February 8, 2024
Citation Information: JCI Insight. 2024;9(3):e163359. https://doi.org/10.1172/jci.insight.163359.
View: Text | PDF
Article has an altmetric score of 43

Blocking IL-6 signaling prevents astrocyte-induced neurodegeneration in an iPSC-based model of Parkinson’s disease

  • Text
  • PDF
Abstract

Parkinson’s disease (PD) is a neurodegenerative disease associated with progressive death of midbrain dopamine (DAn) neurons in the substantia nigra (SN). Since it has been proposed that patients with PD exhibit an overall proinflammatory state, and since astrocytes are key mediators of the inflammation response in the brain, here we sought to address whether astrocyte-mediated inflammatory signaling could contribute to PD neuropathology. For this purpose, we generated astrocytes from induced pluripotent stem cells (iPSCs) representing patients with PD and healthy controls. Transcriptomic analyses identified a unique inflammatory gene expression signature in PD astrocytes compared with controls. In particular, the proinflammatory cytokine IL-6 was found to be highly expressed and released by PD astrocytes and was found to induce toxicity in DAn. Mechanistically, neuronal cell death was mediated by IL-6 receptor (IL-6R) expressed in human PD neurons, leading to downstream activation of STAT3. Blockage of IL-6R by the addition of the FDA-approved anti–IL-6R antibody, Tocilizumab, prevented PD neuronal death. SN neurons overexpressing IL-6R and reactive astrocytes expressing IL-6 were detected in postmortem brain tissue of patients at early stages of PD. Our findings highlight the potential role of astrocyte-mediated inflammatory signaling in neuronal loss in PD and pave the way for the design of future therapeutics.

Authors

Meritxell Pons-Espinal, Lucas Blasco-Agell, Irene Fernandez-Carasa, Pol Andrés-Benito, Angelique di Domenico, Yvonne Richaud-Patin, Valentina Baruffi, Laura Marruecos, Lluís Espinosa, Alicia Garrido, Eduardo Tolosa, Michael J. Edel, Manel Juan Otero, José Luis Mosquera, Isidre Ferrer, Angel Raya, Antonella Consiglio

×

Polyclonal antibodies selectively inhibit tumor growth and invasion and synergize with immune checkpoint inhibitors
Carine Ciron, … , Firas Bassissi, Bernard Vanhove
Carine Ciron, … , Firas Bassissi, Bernard Vanhove
Published December 12, 2023
Citation Information: JCI Insight. 2024;9(3):e166231. https://doi.org/10.1172/jci.insight.166231.
View: Text | PDF
Article has an altmetric score of 5

Polyclonal antibodies selectively inhibit tumor growth and invasion and synergize with immune checkpoint inhibitors

  • Text
  • PDF
Abstract

Heterologous polyclonal antibodies (pAb) were shown to possess oncolytic properties a century ago with reported clinical responses. More recent preclinical models confirmed pAb efficacy, though their ability to tackle complex target antigens reduces susceptibility to tumor escape. Owing to the recent availability of glyco-humanized pAb (GH-pAb) with acceptable clinical toxicology profile, we revisited use of pAb in oncology and highlighted their therapeutic potential against multiple cancer types. Murine antitumor pAb were generated after repeated immunization of rabbits with murine tumor cell lines from hepatocarcinoma, melanoma, and colorectal cancers. Antitumor pAb recognized and showed cytotoxicity against their targets without cross-reactivity with healthy tissues. In vivo, pAb are effective alone; moreover, these pAb synergize with immune checkpoint inhibitors like anti–PD-L1 in several cancer models. They elicited an antitumor host immune response and prevented metastases. The anticancer activity of pAb was also confirmed in xenografted NMRI nude mice using GH-pAb produced by repeated immunization of pigs with human tumor cell lines. In conclusion, the availability of bioengineered GH-pAb allows for revisiting of passive immunotherapy with oncolytic pAb to fight against solid tumor and cancer metastasis.

Authors

Carine Ciron, Pierre Morice, Juliette Rousse, Patrice Roy, Pierre-Joseph Royer, Olivier Gauthier, Sophie Brouard, Odile Duvaux, Firas Bassissi, Bernard Vanhove

×

Sema6D forward signaling impairs T cell activation and proliferation in head and neck cancer
Takashi Hirai, … , Hidenori Inohara, Atsushi Kumanogoh
Takashi Hirai, … , Hidenori Inohara, Atsushi Kumanogoh
Published February 8, 2024
Citation Information: JCI Insight. 2024;9(3):e166349. https://doi.org/10.1172/jci.insight.166349.
View: Text | PDF
Article has an altmetric score of 2

Sema6D forward signaling impairs T cell activation and proliferation in head and neck cancer

  • Text
  • PDF
Abstract

Immune checkpoint inhibitors (ICIs) are indicated for a diverse range of cancer types, and characterizing the tumor immune microenvironment is critical for optimizing therapeutic strategies, including ICIs. T cell infiltration and activation status in the tumor microenvironment greatly affects the efficacy of ICIs. Here, we show that semaphorin 6D (Sema6D) forward signaling, which is reportedly involved in coordinating the orientation of cell development and migration as a guidance factor, impaired the infiltration and activation of tumor-specific CD8+ T cells in murine oral tumors. Sema6D expressed by nonhematopoietic cells was responsible for this phenotype. Plexin-A4, a receptor for Sema6D, inhibited T cell infiltration and partially suppressed CD8+ T cell activation and proliferation induced by Sema6D stimulation. Moreover, mouse oral tumors, which are resistant to PD-1–blocking treatment in wild-type mice, showed a response to the treatment in Sema6d-KO mice. Finally, analyses of public data sets of human head and neck squamous cell carcinoma, pan-cancer cohorts, and a retrospective cohort study showed that SEMA6D was mainly expressed by nonhematopoietic cells such as cancer cells, and SEMA6D expression was significantly negatively correlated with CD8A, PDCD1, IFNG, and GZMB expression. Thus, targeting Sema6D forward signaling is a promising option for increasing ICI efficacy.

Authors

Takashi Hirai, Yujiro Naito, Shohei Koyama, Yoshimitsu Nakanishi, Kentaro Masuhiro, Mayuko Izumi, Tomoki Kuge, Maiko Naito, Yumiko Mizuno, Yuta Yamaguchi, Sujin Kang, Moto Yaga, Yu Futami, Satoshi Nojima, Masayuki Nishide, Takayoshi Morita, Yasuhiro Kato, Takeshi Tsuda, Norihiko Takemoto, Yumi Kinugasa-Katayama, Taiki Aoshi, Jordan Kelly Villa, Kazuo Yamashita, Tomohiro Enokida, Yuta Hoshi, Kazuto Matsuura, Makoto Tahara, Hyota Takamatsu, Yoshito Takeda, Hidenori Inohara, Atsushi Kumanogoh

×

Abnormalities in microbiota/butyrate/FFAR3 signaling in aging gut impair brain function
Sidharth P. Mishra, … , Sushil G. Rane, Hariom Yadav
Sidharth P. Mishra, … , Sushil G. Rane, Hariom Yadav
Published February 8, 2024
Citation Information: JCI Insight. 2024;9(3):e168443. https://doi.org/10.1172/jci.insight.168443.
View: Text | PDF
Article has an altmetric score of 2

Abnormalities in microbiota/butyrate/FFAR3 signaling in aging gut impair brain function

  • Text
  • PDF
Abstract

Aging-related abnormalities in gut microbiota are associated with cognitive decline, depression, and anxiety, but underlying mechanisms remain unstudied. Here, our study demonstrated that transplanting old gut microbiota to young mice induced inflammation in the gut and brain coupled with cognitive decline, depression, and anxiety. We observed diminished mucin formation and increased gut permeability (“leaky gut”) with a reduction in beneficial metabolites like butyrate because of decline in butyrate-producing bacteria in the aged gut microbiota. This led to suppressed expression of butyrate receptors, free fatty acid receptors 2 and 3 (FFAR2/3). Administering butyrate alleviated inflammation, restored mucin expression and gut barriers, and corrected brain dysfunction. Furthermore, young mice with intestine-specific loss of FFAR2/3 exhibited gut and brain abnormalities akin to those in older mice. Our results demonstrate that reduced butyrate-producing bacteria in aged gut microbiota result in low butyrate levels and reduced FFAR2/3 signaling, leading to suppressed mucin formation that increases gut permeability, inflammation, and brain abnormalities. These findings underscore the significance of butyrate-FFAR2/3 agonism as a potential strategy to mitigate aged gut microbiota–induced detrimental effects on gut and brain health in older adults.

Authors

Sidharth P. Mishra, Shalini Jain, Bo Wang, Shaohua Wang, Brandi C. Miller, Jea Y. Lee, Cesar V. Borlongan, Lin Jiang, Julie Pollak, Subhash Taraphder, Brian T. Layden, Sushil G. Rane, Hariom Yadav

×

Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas
Helena Mazuelas, … , Meritxell Carrió, Eduard Serra
Helena Mazuelas, … , Meritxell Carrió, Eduard Serra
Published January 4, 2024
Citation Information: JCI Insight. 2024;9(3):e168826. https://doi.org/10.1172/jci.insight.168826.
View: Text | PDF
Article has an altmetric score of 30

Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas

  • Text
  • PDF
Abstract

Cutaneous neurofibromas (cNFs) are benign Schwann cell (SC) tumors arising from subepidermal glia. Individuals with neurofibromatosis type 1 (NF1) may develop thousands of cNFs, which greatly affect their quality of life. cNF growth is driven by the proliferation of NF1–/– SCs and their interaction with the NF1+/– microenvironment. We analyzed the crosstalk between human cNF-derived SCs and fibroblasts (FBs), identifying an expression signature specific to the SC-FB interaction. We validated the secretion of proteins involved in immune cell migration, suggesting a role of SC-FB crosstalk in immune cell recruitment. The signature also captured components of developmental signaling pathways, including the cAMP elevator G protein–coupled receptor 68 (GPR68). Activation of Gpr68 by ogerin in combination with the MEK inhibitor (MEKi) selumetinib reduced viability and induced differentiation and death of human cNF-derived primary SCs, a result corroborated using an induced pluripotent stem cell–derived 3D neurofibromasphere model. Similar results were obtained using other Gpr68 activators or cAMP analogs/adenylyl cyclase activators in combination with selumetinib. Interestingly, whereas primary SC cultures restarted their proliferation after treatment with selumetinib alone was stopped, the combination of ogerin-selumetinib elicited a permanent halt on SC expansion that persisted after drug removal. These results indicate that unbalancing the Ras and cAMP pathways by combining MEKi and cAMP elevators could be used as a potential treatment for cNFs.

Authors

Helena Mazuelas, Miriam Magallón-Lorenz, Itziar Uriarte-Arrazola, Alejandro Negro, Inma Rosas, Ignacio Blanco, Elisabeth Castellanos, Conxi Lázaro, Bernat Gel, Meritxell Carrió, Eduard Serra

×

Eosinophils restrain humoral alloimmunity after lung transplantation
Zhongcheng Mei, … , Elizabeth A. Jacobsen, Alexander S. Krupnick
Zhongcheng Mei, … , Elizabeth A. Jacobsen, Alexander S. Krupnick
Published February 8, 2024
Citation Information: JCI Insight. 2024;9(3):e168911. https://doi.org/10.1172/jci.insight.168911.
View: Text | PDF
Article has an altmetric score of 4

Eosinophils restrain humoral alloimmunity after lung transplantation

  • Text
  • PDF
Abstract

While the function of many leukocytes in transplant biology has been well defined, the role of eosinophils is controversial and remains poorly explored. Conflicting data exist regarding eosinophils’ role in alloimmunity. Due to their prevalence in the lung, and their defined role in other pulmonary pathologies such as asthma, we set out to explore the role of eosinophils in the long-term maintenance of the lung allograft. We noted that depletion of eosinophils results in the generation of donor-specific antibodies. Eosinophil depletion increased memory B cell, plasma cell, and antibody-secreting cell differentiation and resulted in de novo generation of follicular germinal centers. Germinal center formation depended on the expansion of CD4+Foxp3–Bcl6+CXCR5+PD-1+ T follicular helper (Tfh) cells, which increase in number after eosinophil depletion. Mechanistically, we demonstrate that eosinophils prevent Tfh cell generation by acting as the dominant source of IFN-γ in an established lung allograft, thus facilitating Th1 rather than Tfh polarization of naive CD4+ T cells. Our data thus describe what we believe is a unique and previously unknown role for eosinophils in maintaining allograft tolerance and suggest that indiscriminate administration of eosinophil-lytic corticosteroids for treatment of acute cellular rejection may inadvertently promote humoral alloimmunity.

Authors

Zhongcheng Mei, May A. Khalil, Yizhan Guo, Dongge Li, Anirban Banerjee, Yuriko Terada, Yuhei Yokoyama, Christina Kratzmeier, Kelly Chen, Lushen Li, Christine L. Lau, Jean-Paul Courneya, Irina G. Luzina, Sergei P. Atamas, Andrew E. Gelman, Daniel Kreisel, Elizabeth A. Jacobsen, Alexander S. Krupnick

×

Gene coexpression networks reveal a broad role for lncRNAs in inflammatory bowel disease
John L. Johnson, … , Katherine A. Fitzgerald, Kasper Hoebe
John L. Johnson, … , Katherine A. Fitzgerald, Kasper Hoebe
Published February 8, 2024
Citation Information: JCI Insight. 2024;9(3):e168988. https://doi.org/10.1172/jci.insight.168988.
View: Text | PDF
Article has an altmetric score of 2

Gene coexpression networks reveal a broad role for lncRNAs in inflammatory bowel disease

  • Text
  • PDF
Abstract

The role of long noncoding RNAs (lncRNAs) in disease is incompletely understood, but their regulation of inflammation is increasingly appreciated. We addressed the extent of lncRNA involvement in inflammatory bowel disease (IBD) using biopsy-derived RNA-sequencing data from a large cohort of deeply phenotyped patients with IBD. Weighted gene correlation network analysis revealed gene modules of lncRNAs coexpressed with protein-coding genes enriched for biological pathways, correlated with epithelial and immune cell signatures, or correlated with distal colon expression. Correlation of modules with clinical features uncovered a module correlated with disease severity, with an enriched interferon response signature containing the hub lncRNA IRF1-AS1. Connecting genes to IBD-associated single nucleotide polymorphisms (SNPs) revealed an enrichment of SNP-adjacent lncRNAs in biologically relevant modules. Ulcerative colitis–specific SNPs were enriched in distal colon–related modules, suggesting that disease-specific mechanisms may result from altered lncRNA expression. The function of the IBD-associated SNP-adjacent lncRNA IRF1-AS1 was explored in human myeloid cells, and our results suggested IRF1-AS1 promoted optimal production of TNF-α, IL-6, and IL-23. A CRISPR/Cas9-mediated activation screen in THP-1 cells revealed several lncRNAs that modulated LPS-induced TNF-α responses. Overall, this study uncovered the expression patterns of lncRNAs in IBD that identify functional, disease-relevant lncRNAs.

Authors

John L. Johnson, Davit Sargsyan, Eric M. Neiman, Amy Hart, Aleksandar Stojmirovic, Roman Kosoy, Haritz Irizar, Mayte Suárez-Fariñas, Won-Min Song, Carmen Argmann, Stefan Avey, Liraz Shmuel-Galia, Tim Vierbuchen, Gerold Bongers, Yu Sun, Leonard Edelstein, Jacqueline Perrigoue, Jennifer E. Towne, Aisling O’Hara Hall, Katherine A. Fitzgerald, Kasper Hoebe

×

Macrophage RAGE activation is proinflammatory in NASH
Gopanandan Parthasarathy, … , Sumera I. Ilyas, Harmeet Malhi
Gopanandan Parthasarathy, … , Sumera I. Ilyas, Harmeet Malhi
Published January 4, 2024
Citation Information: JCI Insight. 2024;9(3):e169138. https://doi.org/10.1172/jci.insight.169138.
View: Text | PDF
Article has an altmetric score of 5

Macrophage RAGE activation is proinflammatory in NASH

  • Text
  • PDF
Abstract

Intrahepatic macrophages in nonalcoholic steatohepatitis (NASH) are heterogenous and include proinflammatory recruited monocyte-derived macrophages. The receptor for advanced glycation endproducts (RAGE) is expressed on macrophages and can be activated by damage associated molecular patterns (DAMPs) upregulated in NASH, yet the role of macrophage-specific RAGE signaling in NASH is unclear. Therefore, we hypothesized that RAGE-expressing macrophages are proinflammatory and mediate liver inflammation in NASH. Compared with healthy controls, RAGE expression was increased in liver biopsies from patients with NASH. In a high-fat, -fructose, and -cholesterol–induced (FFC)-induced murine model of NASH, RAGE expression was increased, specifically on recruited macrophages. FFC mice that received a pharmacological inhibitor of RAGE (TTP488), and myeloid-specific RAGE KO mice (RAGE-MKO) had attenuated liver injury associated with a reduced accumulation of RAGE+ recruited macrophages. Transcriptomics analysis suggested that pathways of macrophage and T cell activation were upregulated by FFC diet, inhibited by TTP488 treatment, and reduced in RAGE-MKO mice. Correspondingly, the secretome of ligand-stimulated BM-derived macrophages from RAGE-MKO mice had an attenuated capacity to activate CD8+ T cells. Our data implicate RAGE as what we propose to be a novel and potentially targetable mediator of the proinflammatory signaling of recruited macrophages in NASH.

Authors

Gopanandan Parthasarathy, Amy S. Mauer, Naresh Golla, P. Vineeth Daniel, Lily H. Kim, Guneet S. Sidhu, George W. Marek III, Emilien Loeuillard, Anuradha Krishnan, Hyun Se Kim Lee, Kevin D. Pavelko, Michael Charlton, Petra Hirsova, Sumera I. Ilyas, Harmeet Malhi

×

Extended time frame for restoring inner ear function through gene therapy in Usher1G preclinical model
Ghizlene Lahlou, … , Christine Petit, Saaid Safieddine
Ghizlene Lahlou, … , Christine Petit, Saaid Safieddine
Published January 9, 2024
Citation Information: JCI Insight. 2024;9(3):e169504. https://doi.org/10.1172/jci.insight.169504.
View: Text | PDF
Article has an altmetric score of 1

Extended time frame for restoring inner ear function through gene therapy in Usher1G preclinical model

  • Text
  • PDF
Abstract

Neonatal gene therapy has been shown to prevent inner ear dysfunction in mouse models of Usher syndrome type I (USH1), the most common genetic cause of combined deafness-blindness and vestibular dysfunction. However, hearing onset occurs after birth in mice and in utero in humans, making it questionable how to transpose murine gene therapy outcomes to clinical settings. Here, we sought to extend the therapeutic time window in a mouse model for USH1G to periods corresponding to human neonatal stages, more suitable for intervention in patients. Mice with deletion of Ush1g (Ush1g–/–) were subjected to gene therapy after the hearing onset. The rescue of inner ear hair cell structure was evaluated by confocal imaging and electron microscopy. Hearing and vestibular function were assessed by recordings of the auditory brain stem response and vestibulo-ocular reflex and by locomotor tests. Up to P21, gene therapy significantly restored both the hearing and balance deficits in Ush1g–/– mice. However, beyond this age and up to P30, vestibular function was restored but not hearing. Our data show that effective gene therapy is possible in Ush1g–/– mice well beyond neonatal stages, implying that the therapeutic window for USH1G may be wide enough to be transposable to newborn humans.

Authors

Ghizlene Lahlou, Charlotte Calvet, François Simon, Vincent Michel, Lauranne Alciato, Baptiste Plion, Jacques Boutet de Monvel, Marie-José Lecomte, Mathieu Beraneck, Christine Petit, Saaid Safieddine

×

Inhibition of cysteine protease cathepsin L increases the level and activity of lysosomal glucocerebrosidase
Myung Jong Kim, … , Thomas Reinheckel, Dimitri Krainc
Myung Jong Kim, … , Thomas Reinheckel, Dimitri Krainc
Published February 8, 2024
Citation Information: JCI Insight. ;9(3):e169594. https://doi.org/10.1172/jci.insight.169594.
View: Text | PDF
Article has an altmetric score of 1

Inhibition of cysteine protease cathepsin L increases the level and activity of lysosomal glucocerebrosidase

  • Text
  • PDF
Abstract

The glucocerebrosidase (GCase) encoded by the GBA1 gene hydrolyzes glucosylceramide (GluCer) to ceramide and glucose in lysosomes. Homozygous or compound heterozygous GBA1 mutations cause the lysosomal storage disease Gaucher disease (GD) due to severe loss of GCase activity. Loss-of-function variants in the GBA1 gene are also the most common genetic risk factor for Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). Restoring lysosomal GCase activity represents an important therapeutic approach for GBA1-associated diseases. We hypothesized that increasing the stability of lysosomal GCase protein could correct deficient GCase activity in these conditions. However, it remains unknown how GCase stability is regulated in the lysosome. We found that cathepsin L, a lysosomal cysteine protease, cleaves GCase and regulates its stability. In support of these data, GCase protein was elevated in the brain of cathepsin L–KO mice. Chemical inhibition of cathepsin L increased both GCase levels and activity in fibroblasts from patients with GD. Importantly, inhibition of cathepsin L in dopaminergic neurons from a patient GBA1-PD led to increased GCase levels and activity as well as reduced phosphorylated α-synuclein. These results suggest that targeting cathepsin L–mediated GCase degradation represents a potential therapeutic strategy for GCase deficiency in PD and related disorders that exhibit decreased GCase activity.

Authors

Myung Jong Kim, Soojin Kim, Thomas Reinheckel, Dimitri Krainc

×

Tertiary lymphoid structures sustain cutaneous B cell activity in hidradenitis suppurativa
Margaret M. Lowe, … , Michael D. Rosenblum, Joshua M. Moreau
Margaret M. Lowe, … , Michael D. Rosenblum, Joshua M. Moreau
Published December 19, 2023
Citation Information: JCI Insight. 2024;9(3):e169870. https://doi.org/10.1172/jci.insight.169870.
View: Text | PDF
Article has an altmetric score of 4

Tertiary lymphoid structures sustain cutaneous B cell activity in hidradenitis suppurativa

  • Text
  • PDF
Abstract

Hidradenitis suppurativa (HS) is a chronic skin condition affecting approximately 1% of the US population. HS skin lesions are highly inflammatory and characterized by a large immune infiltrate. While B cells and plasma cells comprise a major component of this immune milieu, the biology and the contribution of these cells in HS pathogenesis are unclear. We aimed to investigate the dynamics and microenvironmental interactions of B cells within cutaneous HS lesions. Combining histological analysis, single-cell RNA sequencing, and spatial transcriptomics profiling of HS lesions, we defined the tissue microenvironment relative to B cell activity within this disease. Our findings identified tertiary lymphoid structures (TLSs) within HS lesions and described organized interactions among T cells, B cells, antigen-presenting cells, and skin stroma. We found evidence that B cells within HS TLSs actively underwent maturation, including participation in germinal center reactions and class switch recombination. Moreover, skin stroma and accumulating T cells were primed to support the formation of TLSs and facilitate B cell recruitment during HS. Our data definitively demonstrated the presence of TLSs in lesional HS skin and point to ongoing cutaneous B cell maturation through class switch recombination and affinity maturation during disease progression in this inflamed nonlymphoid tissue.

Authors

Margaret M. Lowe, Jarish N. Cohen, Madison I. Moss, Sean Clancy, James P. Adler, Ashley E. Yates, Haley B. Naik, Rashi Yadav, Mariela Pauli, Ian Taylor, Austin McKay, Hobart Harris, Esther Kim, Scott L. Hansen, Michael D. Rosenblum, Joshua M. Moreau

×

Scaffold protein SH3BP2 signalosome is pivotal for immune activation in nephrotic syndrome
Tarak Srivastava, … , Yasuyoshi Ueki, Mukut Sharma
Tarak Srivastava, … , Yasuyoshi Ueki, Mukut Sharma
Published December 21, 2023
Citation Information: JCI Insight. 2024;9(3):e170055. https://doi.org/10.1172/jci.insight.170055.
View: Text | PDF
Article has an altmetric score of 2

Scaffold protein SH3BP2 signalosome is pivotal for immune activation in nephrotic syndrome

  • Text
  • PDF
Abstract

Despite clinical use of immunosuppressive agents, the immunopathogenesis of minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS) remains unclear. Src homology 3-binding protein 2 (SH3BP2), a scaffold protein, forms an immune signaling complex (signalosome) with 17 other proteins, including phospholipase Cγ2 (PLCγ2) and Rho-guanine nucleotide exchange factor VAV2 (VAV2). Bioinformatic analysis of human glomerular transcriptome (Nephrotic Syndrome Study Network cohort) revealed upregulated SH3BP2 in MCD and FSGS. The SH3BP2 signalosome score and downstream MyD88, TRIF, and NFATc1 were significantly upregulated in MCD and FSGS. Immune pathway activation scores for Toll-like receptors, cytokine-cytokine receptor, and NOD-like receptors were increased in FSGS. Lower SH3BP2 signalosome score was associated with MCD, higher estimated glomerular filtration rate, and remission. Further work using Sh3bp2KI/KI transgenic mice with a gain-in-function mutation showed ~6-fold and ~25-fold increases in albuminuria at 4 and 12 weeks, respectively. Decreased serum albumin and unchanged serum creatinine were observed at 12 weeks. Sh3bp2KI/KI kidney morphology appeared normal except for increased mesangial cellularity and patchy foot process fusion without electron-dense deposits. SH3BP2 co-immunoprecipitated with PLCγ2 and VAV2 in human podocytes, underscoring the importance of SH3BP2 in immune activation. SH3BP2 and its binding partners may determine the immune activation pathways resulting in podocyte injury leading to loss of the glomerular filtration barrier.

Authors

Tarak Srivastava, Robert E. Garola, Jianping Zhou, Varun C. Boinpelly, Mohammad H. Rezaiekhaligh, Trupti Joshi, Yuexu Jiang, Diba Ebadi, Siddarth Sharma, Christine Sethna, Vincent S. Staggs, Ram Sharma, Debbie S. Gipson, Wei Hao, Yujie Wang, Laura H. Mariani, Jeffrey B. Hodgin, Robert Rottapel, Teruhito Yoshitaka, Yasuyoshi Ueki, Mukut Sharma

×

Evolutionary mode and timing of dissemination of high-grade serous carcinomas
Anita Sveen, … , Ben Davidson, Ragnhild A. Lothe
Anita Sveen, … , Ben Davidson, Ragnhild A. Lothe
Published January 4, 2024
Citation Information: JCI Insight. 2024;9(3):e170423. https://doi.org/10.1172/jci.insight.170423.
View: Text | PDF
Article has an altmetric score of 1

Evolutionary mode and timing of dissemination of high-grade serous carcinomas

  • Text
  • PDF
Abstract

Dissemination within the peritoneal cavity is a main determinant of poor patient outcomes from high-grade serous carcinomas (HGSCs). The dissemination process is poorly understood from a cancer evolutionary perspective. We reconstructed the evolutionary trajectories across a median of 5 tumor sites and regions from each of 23 patients based on deep whole-exome sequencing. Polyclonal cancer origin was detected in 1 patient. Ovarian tumors had more complex subclonal architectures than other intraperitoneal tumors in each patient, which indicated that tumors developed earlier in the ovaries. Three common modes of dissemination were identified, including monoclonal or polyclonal dissemination of monophyletic (linear) or polyphyletic (branched) subclones. Mutation profiles of initial or disseminated clones varied greatly among cancers, but recurrent mutations were found in 7 cancer-critical genes, including TP53, BRCA1, BRCA2, and DNMT3A, and in the PI3K/AKT1 pathway. Disseminated clones developed late in the evolutionary trajectory models of most cancers, in particular in cancers with DNA damage repair deficiency. Polyclonal dissemination was predicted to occur predominantly as a single and rapid wave, but chemotherapy exposure was associated with higher genomic diversity of disseminated clones. In conclusion, we described three common evolutionary dissemination modes across HGSCs and proposed factors associated with dissemination diversity.

Authors

Anita Sveen, Bjarne Johannessen, Solveig M.K. Klokkerud, Sigrid M. Kraggerud, Leonardo A. Meza-Zepeda, Merete Bjørnslett, Katharina Bischof, Ola Myklebost, Kjetil Taskén, Rolf I. Skotheim, Anne Dørum, Ben Davidson, Ragnhild A. Lothe

×

Linking adipose tissue eosinophils, IL-4, and leptin in human obesity and insulin resistance
James D. Hernandez, … , Elizabeth A. Jacobsen, Eleanna De Filippis
James D. Hernandez, … , Elizabeth A. Jacobsen, Eleanna De Filippis
Published January 11, 2024
Citation Information: JCI Insight. 2024;9(3):e170772. https://doi.org/10.1172/jci.insight.170772.
View: Text | PDF Clinical Research and Public Health
Article has an altmetric score of 1

Linking adipose tissue eosinophils, IL-4, and leptin in human obesity and insulin resistance

  • Text
  • PDF
Abstract

BACKGROUND Obesity is a multifactorial disease with adverse health implications including insulin resistance (IR). In patients with obesity, the presence of high circulating levels of leptin, deemed hyperleptinemia, is associated with IR. Recent data in mice with diet-induced obesity (DIO) show that a partial reduction in leptin levels improves IR. Additional animal studies demonstrate that IL-4 decreases leptin levels. In rodents, resident adipose tissue eosinophils (AT-EOS) are the main source of IL-4 and are instrumental in maintaining metabolic homeostasis. A marked reduction in AT-EOS content is observed in animal models of DIO. These observations have not been explored in humans.METHODS We analyzed AT from individuals with obesity and age-matched lean counterparts for AT-EOS content, IL-4, circulating leptin levels, and measures of IR.RESULTS Our results show that individuals with obesity (n = 15) had a significant reduction in AT-EOS content (P < 0.01), decreased AT–IL-4 gene expression (P = 0.02), and decreased IL-4 plasma levels (P < 0.05) in addition to expected IR (P < 0.001) and hyperleptinemia (P < 0.01) compared with lean subjects (n = 15). AT-EOS content inversely correlated with BMI (P = 0.002) and IR (P = 0.005). Ex vivo AT explants and in vitro cell culture of primary human mature adipocytes exposed to either IL-4 or EOS conditioned media produced less leptin (P < 0.05).CONCLUSION Our results suggest that IL-4 acts as a link between EOS, AT, and leptin production. Future studies exploring this interaction may identify an avenue for the treatment of obesity and its complications through amelioration of hyperleptinemia.TRIAL REGISTRATION Clinicaltrials.gov NCT02378077 & NCT04234295.

Authors

James D. Hernandez, Ting Li, Hamza Ghannam, Cassandra M. Rau, Mia Y. Masuda, James A. Madura II, Elizabeth A. Jacobsen, Eleanna De Filippis

×

Attenuation of HOIL-1L ligase activity promotes systemic autoimmune disorders by augmenting linear ubiquitin signaling
Yasuhiro Fuseya, … , Chikashi Terao, Kazuhiro Iwai
Yasuhiro Fuseya, … , Chikashi Terao, Kazuhiro Iwai
Published February 8, 2024
Citation Information: JCI Insight. 2024;9(3):e171108. https://doi.org/10.1172/jci.insight.171108.
View: Text | PDF
Article has an altmetric score of 3

Attenuation of HOIL-1L ligase activity promotes systemic autoimmune disorders by augmenting linear ubiquitin signaling

  • Text
  • PDF
Abstract

Linear ubiquitin chains, which are generated specifically by the linear ubiquitin assembly complex (LUBAC) ubiquitin ligase, play crucial roles in immune signaling, including NF-κB activation. LUBAC comprises catalytic large isoform of heme-oxidized iron regulatory protein 2 ubiquitin ligase 1 (HOIL-1L) interacting protein (HOIP), accessory HOIL-1L, and SHANK-associated RH domain-interacting protein (SHARPIN). Deletion of the ubiquitin ligase activity of HOIL-1L, an accessory ligase of LUBAC, augments LUBAC functions by enhancing LUBAC-mediated linear ubiquitination, which is catalyzed by HOIP. Here, we show that HOIL-1L ΔRING1 mice, which exhibit augmented LUBAC functions upon loss of the HOIL-1L ligase, developed systemic lupus erythematosus (SLE) and Sjögren’s syndrome in a female-dominant fashion. Augmented LUBAC activity led to hyperactivation of both lymphoid and myeloid cells. In line with the findings in mice, we sought to identify missense single nucleotide polymorphisms/variations of the RBCK1/HOIL-1L gene in humans that attenuate HOIL-1L ligase activity. We found that the R464H variant, which is encoded by rs774507518 within the RBCK1/HOIL-1L gene, attenuated HOIL-1L ligase activity and augmented LUBAC-mediated immune signaling, including that mediated by Toll-like receptors. We also found that rs774507518 was enriched significantly in patients with SLE, strongly suggesting that RBCK1/HOIL-1L is an SLE susceptibility gene and that augmented linear ubiquitin signaling generated specifically by LUBAC underlies the pathogenesis of this prototype systemic autoimmune disease.

Authors

Yasuhiro Fuseya, Keiichiro Kadoba, Xiaoxi Liu, Hiroyuki Suetsugu, Takeshi Iwasaki, Koichiro Ohmura, Takayuki Sumida, Yuta Kochi, Akio Morinobu, Chikashi Terao, Kazuhiro Iwai

×

IRF5 governs macrophage adventitial infiltration to fuel abdominal aortic aneurysm formation
Yidong Wang, … , Zhejun Cai, Meixiang Xiang
Yidong Wang, … , Zhejun Cai, Meixiang Xiang
Published January 4, 2024
Citation Information: JCI Insight. 2024;9(3):e171488. https://doi.org/10.1172/jci.insight.171488.
View: Text | PDF
Article has an altmetric score of 1

IRF5 governs macrophage adventitial infiltration to fuel abdominal aortic aneurysm formation

  • Text
  • PDF
Abstract

Abdominal aortic aneurysm (AAA) is a chronic inflammatory disease characterized by the expansion of the aortic wall. One of the most significant features is the infiltration of macrophages in the adventitia, which drives vasculature remodeling. The role of macrophage-derived interferon regulatory factor 5 (IRF5) in macrophage infiltration and AAA formation remains unknown. RNA sequencing of AAA adventitia identified Irf5 as the top significantly increased transcription factor that is predominantly expressed in macrophages. Global and myeloid cell–specific deficiency of Irf5 reduced AAA progression, with a marked reduction in macrophage infiltration. Further cellular investigations indicated that IRF5 promotes macrophage migration by direct regulation of downstream phosphoinositide 3-kinase γ (PI3Kγ, Pik3cg). Pik3cg ablation hindered AAA progression, and myeloid cell–specific salvage of Pik3cg restored AAA progression and macrophage infiltration derived from Irf5 deficiency. Finally, we found that IRF5 and PI3Kγ expression in the adventitia is significantly increased in patients with AAA. These findings reveal that the IRF5-dependent regulation of PI3Kγ is essential for AAA formation.

Authors

Yidong Wang, Zhenjie Liu, Shen Song, Jianfang Wang, Chunna Jin, Liangliang Jia, Yuankun Ma, Tan Yuan, Zhejun Cai, Meixiang Xiang

×

BDNF and cAMP are neuroprotective in a porcine model of traumatic optic neuropathy
Kathleen Heng, … , Albert Y. Wu, Jeffrey L. Goldberg
Kathleen Heng, … , Albert Y. Wu, Jeffrey L. Goldberg
Published January 9, 2024
Citation Information: JCI Insight. 2024;9(3):e172935. https://doi.org/10.1172/jci.insight.172935.
View: Text | PDF
Article has an altmetric score of 3

BDNF and cAMP are neuroprotective in a porcine model of traumatic optic neuropathy

  • Text
  • PDF
Abstract

Traumatic optic neuropathy (TON) is a devastating condition that can occur after blunt or penetrating trauma to the head, leading to visual impairment or blindness. Despite these debilitating effects, no clinically available therapeutic targets neuroprotection or promotes axon regeneration in this or any optic neuropathy. Limited data in large-animal models are a major obstacle to advancing treatments toward clinical therapeutics. To address this issue, we refined a surgical model of TON in Yucatan minipigs. First, we validated the model by demonstrating visual impairment by flash visual-evoked potential and retinal ganglion cell degeneration and death. Next, we developed and optimized a delivery method and nontoxic dosing of intravitreal brain-derived neurotrophic factor (BDNF) and cAMP. Finally, we showed that intravitreal injection of BDNF and cAMP rescued visual function and protected against retinal ganglion cell death and optic nerve axon degeneration. Together these data in a preclinical large-animal model advance our understanding of and ability to model TON and further identify and develop candidate clinical therapeutics.

Authors

Kathleen Heng, Brent K. Young, BaoXiang Li, Ashley D. Nies, Xin Xia, Runxia R. Wen, Roopa Dalal, Gregory T. Bramblett, Andrew W. Holt, Jeffery M. Cleland, Jason N. Harris, Albert Y. Wu, Jeffrey L. Goldberg

×

The super-healing MRL strain promotes muscle growth in muscular dystrophy through a regenerative extracellular matrix
Joseph G. O’Brien, … , Alexis R. Demonbreun, Elizabeth M. McNally
Joseph G. O’Brien, … , Alexis R. Demonbreun, Elizabeth M. McNally
Published January 4, 2024
Citation Information: JCI Insight. 2024;9(3):e173246. https://doi.org/10.1172/jci.insight.173246.
View: Text | PDF
Article has an altmetric score of 9

The super-healing MRL strain promotes muscle growth in muscular dystrophy through a regenerative extracellular matrix

  • Text
  • PDF
Abstract

The Murphy Roths Large (MRL) mouse strain has “super-healing” properties that enhance recovery from injury. In mice, the DBA/2J strain intensifies many aspects of muscular dystrophy, so we evaluated the ability of the MRL strain to suppress muscular dystrophy in the Sgcg-null mouse model of limb girdle muscular dystrophy. A comparative analysis of Sgcg-null mice in the DBA/2J versus MRL strains showed greater myofiber regeneration, with reduced structural degradation of muscle in the MRL strain. Transcriptomic profiling of dystrophic muscle indicated strain-dependent expression of extracellular matrix (ECM) and TGF-β signaling genes. To investigate the MRL ECM, cellular components were removed from dystrophic muscle sections to generate decellularized myoscaffolds. Decellularized myoscaffolds from dystrophic mice in the protective MRL strain had significantly less deposition of collagen and matrix-bound TGF-β1 and TGF-β3 throughout the matrix. Dystrophic myoscaffolds from the MRL background, but not the DBA/2J background, were enriched in myokines like IGF-1 and IL-6. C2C12 myoblasts seeded onto decellularized matrices from Sgcg–/– MRL and Sgcg–/– DBA/2J muscles showed the MRL background induced greater myoblast differentiation compared with dystrophic DBA/2J myoscaffolds. Thus, the MRL background imparts its effect through a highly regenerative ECM, which is active even in muscular dystrophy.

Authors

Joseph G. O’Brien, Alexander B. Willis, Ashlee M. Long, Jason Kwon, GaHyun Lee, Frank W. Li, Patrick G.T. Page, Andy H. Vo, Michele Hadhazy, Melissa J. Spencer, Rachelle H. Crosbie, Alexis R. Demonbreun, Elizabeth M. McNally

×

Predictors of HIV rebound differ by timing of antiretroviral therapy initiation
Jonathan Z. Li, … , Davey M. Smith, for the AIDS Clinical Trials Group A5345 Study Team
Jonathan Z. Li, … , Davey M. Smith, for the AIDS Clinical Trials Group A5345 Study Team
Published February 8, 2024
Citation Information: JCI Insight. 2024;9(3):e173864. https://doi.org/10.1172/jci.insight.173864.
View: Text | PDF Clinical Research and Public Health
Article has an altmetric score of 5

Predictors of HIV rebound differ by timing of antiretroviral therapy initiation

  • Text
  • PDF
Abstract

BACKGROUND Identifying factors that predict the timing of HIV rebound after treatment interruption will be crucial for designing and evaluating interventions for HIV remission.METHODS We performed a broad evaluation of viral and immune factors that predict viral rebound (AIDS Clinical Trials Group A5345). Participants initiated antiretroviral therapy (ART) during chronic (N = 33) or early (N = 12) HIV infection with ≥ 2 years of suppressive ART and restarted ART if they had 2 viral loads ≥ 1,000 copies/mL after treatment interruption.RESULTS Compared with chronic-treated participants, early-treated individuals had smaller and fewer transcriptionally active HIV reservoirs. A higher percentage of HIV Gag-specific CD8+ T cell cytotoxic response was associated with lower intact proviral DNA. Predictors of HIV rebound timing differed between early- versus chronic-treated participants, as the strongest reservoir predictor of time to HIV rebound was level of residual viremia in early-treated participants and intact DNA level in chronic-treated individuals. We also identified distinct sets of pre–treatment interruption viral, immune, and inflammatory markers that differentiated participants who had rapid versus slow rebound.CONCLUSION The results provide an in-depth overview of the complex interplay of viral, immunologic, and inflammatory predictors of viral rebound and demonstrate that the timing of ART initiation modifies the features of rapid and slow viral rebound.TRIAL REGISTRATION ClinicalTrials.gov NCT03001128FUNDING NIH National Institute of Allergy and Infectious Diseases, Merck

Authors

Jonathan Z. Li, Meghan Melberg, Autumn Kittilson, Mohamed Abdel-Mohsen, Yijia Li, Evgenia Aga, Ronald J. Bosch, Elizabeth R. Wonderlich, Jennifer Kinslow, Leila B. Giron, Clara Di Germanio, Mark Pilkinton, Lynsay MacLaren, Michael Keefer, Lawrence Fox, Liz Barr, Edward Acosta, Jintanat Ananworanich, Robert Coombs, John Mellors, Steven Deeks, Rajesh T. Gandhi, Michael Busch, Alan Landay, Bernard Macatangay, Davey M. Smith, for the AIDS Clinical Trials Group A5345 Study Team

×

Persistent mucus plugs in proximal airways are consequential for airflow limitation in asthma
Brendan K. Huang, … , John V. Fahy, for the NHLBI Severe Asthma Research Program (SARP)
Brendan K. Huang, … , John V. Fahy, for the NHLBI Severe Asthma Research Program (SARP)
Published December 21, 2023
Citation Information: JCI Insight. 2024;9(3):e174124. https://doi.org/10.1172/jci.insight.174124.
View: Text | PDF Clinical Research and Public Health
Article has an altmetric score of 1

Persistent mucus plugs in proximal airways are consequential for airflow limitation in asthma

  • Text
  • PDF
Abstract

BACKGROUND Information about the size, airway location, and longitudinal behavior of mucus plugs in asthma is needed to understand their role in mechanisms of airflow obstruction and to rationally design muco-active treatments.METHODS CT lung scans from 57 patients with asthma were analyzed to quantify mucus plug size and airway location, and paired CT scans obtained 3 years apart were analyzed to determine plug behavior over time. Radiologist annotations of mucus plugs were incorporated in an image-processing pipeline to generate size and location information that was related to measures of airflow.RESULTS The length distribution of 778 annotated mucus plugs was multimodal, and a 12 mm length defined short (“stubby”, ≤12 mm) and long (“stringy”, >12 mm) plug phenotypes. High mucus plug burden was disproportionately attributable to stringy mucus plugs. Mucus plugs localized predominantly to airway generations 6–9, and 47% of plugs in baseline scans persisted in the same airway for 3 years and fluctuated in length and volume. Mucus plugs in larger proximal generations had greater effects on spirometry measures than plugs in smaller distal generations, and a model of airflow that estimates the increased airway resistance attributable to plugs predicted a greater effect for proximal generations and more numerous mucus plugs.CONCLUSION Persistent mucus plugs in proximal airway generations occur in asthma and demonstrate a stochastic process of formation and resolution over time. Proximal airway mucus plugs are consequential for airflow and are in locations amenable to treatment by inhaled muco-active drugs or bronchoscopy.TRIAL REGISTRATION Clinicaltrials.gov; NCT01718197, NCT01606826, NCT01750411, NCT01761058, NCT01761630, NCT01716494, and NCT01760915.FUNDING AstraZeneca, Boehringer-Ingelheim, Genentech, GlaxoSmithKline, Sanofi–Genzyme–Regeneron, and TEVA provided financial support for study activities at the Coordinating and Clinical Centers beyond the third year of patient follow-up. These companies had no role in study design or data analysis, and the only restriction on the funds was that they be used to support the SARP initiative.

Authors

Brendan K. Huang, Brett M. Elicker, Travis S. Henry, Kimberly G. Kallianos, Lewis D. Hahn, Monica Tang, Franklin Heng, Charles E. McCulloch, Nirav R. Bhakta, Sharmila Majumdar, Jiwoong Choi, Loren C. Denlinger, Sean B. Fain, Annette T. Hastie, Eric A. Hoffman, Elliot Israel, Nizar N. Jarjour, Bruce D. Levy, Dave T. Mauger, Kaharu Sumino, Sally E. Wenzel, Mario Castro, Prescott G. Woodruff, John V. Fahy, for the NHLBI Severe Asthma Research Program (SARP)

×

Cold stress–induced ferroptosis in liver sinusoidal endothelial cells determines liver transplant injury and outcomes
Hidenobu Kojima, … , Douglas G. Farmer, Jerzy W. Kupiec-Weglinski
Hidenobu Kojima, … , Douglas G. Farmer, Jerzy W. Kupiec-Weglinski
Published February 8, 2024
Citation Information: JCI Insight. 2024;9(3):e174354. https://doi.org/10.1172/jci.insight.174354.
View: Text | PDF
Article has an altmetric score of 3

Cold stress–induced ferroptosis in liver sinusoidal endothelial cells determines liver transplant injury and outcomes

  • Text
  • PDF
Abstract

Although cold preservation remains the gold standard in organ transplantation, cold stress–induced cellular injury is a significant problem in clinical orthotopic liver transplantation (OLT). Because a recent study showed that cold stress activates ferroptosis, a form of regulated cell death, we investigated whether and how ferroptosis determines OLT outcomes in mice and humans. Treatment with ferroptosis inhibitor (ferrostatin-1) during cold preservation reduced lipid peroxidation (malondialdehyde; MDA), primarily in liver sinusoidal endothelial cells (LSECs), and alleviated ischemia/reperfusion injury in mouse OLT. Similarly, ferrostatin-1 reduced cell death in cold-stressed LSEC cultures. LSECs deficient in nuclear factor erythroid 2-related factor 2 (NRF2), a critical regulator of ferroptosis, were susceptible to cold stress–induced cell death, concomitant with enhanced endoplasmic reticulum (ER) stress and expression of mitochondrial Ca2+ uptake regulator (MICU1). Indeed, supplementing MICU1 inhibitor reduced ER stress, MDA expression, and cell death in NRF2-deficient but not WT LSECs, suggesting NRF2 is a critical regulator of MICU1-mediated ferroptosis. Consistent with murine data, enhanced liver NRF2 expression reduced MDA levels, hepatocellular damage, and incidence of early allograft dysfunction in human OLT recipients. This translational study provides a clinically applicable strategy in which inhibition of ferroptosis during liver cold preservation mitigates OLT injury by protecting LSECs from peritransplant stress via an NRF2-regulatory mechanism.

Authors

Hidenobu Kojima, Hirofumi Hirao, Kentaro Kadono, Takahiro Ito, Siyuan Yao, Taylor Torgerson, Kenneth J. Dery, Hiroaki Kitajima, Takahiro Ogawa, Fady M. Kaldas, Douglas G. Farmer, Jerzy W. Kupiec-Weglinski

×

Dynamic regulation of hepatic lipid metabolism by torsinA and its activators
Antonio Hernandez-Ono, … , Henry N. Ginsberg, Ji-Yeon Shin
Antonio Hernandez-Ono, … , Henry N. Ginsberg, Ji-Yeon Shin
Published January 9, 2024
Citation Information: JCI Insight. 2024;9(3):e175328. https://doi.org/10.1172/jci.insight.175328.
View: Text | PDF
Article has an altmetric score of 2

Dynamic regulation of hepatic lipid metabolism by torsinA and its activators

  • Text
  • PDF
Abstract

Depletion of torsinA from hepatocytes leads to reduced liver triglyceride secretion and marked hepatic steatosis. TorsinA is an atypical ATPase that lacks intrinsic activity unless it is bound to its activator, lamina-associated polypeptide 1 (LAP1) or luminal domain–like LAP1 (LULL1). We previously demonstrated that depletion of LAP1 from hepatocytes has more modest effects on liver triglyceride secretion and steatosis development than depletion of torsinA. We now show that depletion of LULL1 alone does not significantly decrease triglyceride secretion or cause steatosis. However, simultaneous depletion of both LAP1 and LULL1 leads to defective triglyceride secretion and marked steatosis similar to that observed with depletion of torsinA. Depletion of both LAP1 and torsinA from hepatocytes generated phenotypes similar to those observed with only torsinA depletion, implying that the 2 proteins act in the same pathway in liver lipid metabolism. Our results demonstrate that torsinA and its activators dynamically regulate hepatic lipid metabolism.

Authors

Antonio Hernandez-Ono, Yi Peng Zhao, John W. Murray, Cecilia Östlund, Michael J. Lee, Angsi Shi, William T. Dauer, Howard J. Worman, Henry N. Ginsberg, Ji-Yeon Shin

×

Immunoglobulin replacement products protect against SARS-CoV-2 infection in vivo despite poor neutralizing activity
Ofer Zimmerman, … , Ali H. Ellebedy, Michael S. Diamond
Ofer Zimmerman, … , Ali H. Ellebedy, Michael S. Diamond
Published January 4, 2024
Citation Information: JCI Insight. 2024;9(3):e176359. https://doi.org/10.1172/jci.insight.176359.
View: Text | PDF
Article has an altmetric score of 3

Immunoglobulin replacement products protect against SARS-CoV-2 infection in vivo despite poor neutralizing activity

  • Text
  • PDF
Abstract

Immunoglobulin (IG) replacement products are used routinely in patients with immune deficiency and other immune dysregulation disorders who have poor responses to vaccination and require passive immunity conferred by commercial antibody products. The binding, neutralizing, and protective activity of intravenously administered IG against SARS-CoV-2 emerging variants remains unknown. Here, we tested 198 different IG products manufactured from December 2019 to August 2022. We show that prepandemic IG had no appreciable cross-reactivity or neutralizing activity against SARS-CoV-2. Anti-spike antibody titers and neutralizing activity against SARS-CoV-2 WA1/2020 D614G increased gradually after the pandemic started and reached levels comparable to vaccinated healthy donors 18 months after the diagnosis of the first COVID-19 case in the United States in January 2020. The average time between production to infusion of IG products was 8 months, which resulted in poor neutralization of the variant strain circulating at the time of infusion. Despite limited neutralizing activity, IG prophylaxis with clinically relevant dosing protected susceptible K18-hACE2–transgenic mice against clinical disease, lung infection, and lung inflammation caused by the XBB.1.5 Omicron variant. Moreover, following IG prophylaxis, levels of XBB.1.5 infection in the lung were higher in FcγR-KO mice than in WT mice. Thus, IG replacement products with poor neutralizing activity against evolving SARS-CoV-2 variants likely confer protection to patients with immune deficiency disorders through Fc effector function mechanisms.

Authors

Ofer Zimmerman, Alexa Michelle Altman Doss, Baoling Ying, Chieh-Yu Liang, Samantha R. Mackin, Hannah G. Davis-Adams, Lucas J. Adams, Laura A. VanBlargan, Rita E. Chen, Suzanne M. Scheaffer, Pritesh Desai, Saravanan Raju, Tarisa L. Mantia, Caitlin C. O’Shaughnessy, Jennifer Marie Monroy, H. James Wedner, Christopher J. Rigell, Andrew L. Kau, Tiffany Biason Dy, Zhen Ren, Jackson S. Turner, Jane A. O’Halloran, Rachel M. Presti, Peggy L. Kendall, Daved H. Fremont, Ali H. Ellebedy, Michael S. Diamond

×
Corrigenda
miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2
Enrique Fuentes-Mattei, … , George A. Calin, Roxana S. Redis
Enrique Fuentes-Mattei, … , George A. Calin, Roxana S. Redis
Published February 8, 2024
Citation Information: JCI Insight. 2024;9(3):e178762. https://doi.org/10.1172/jci.insight.178762.
View: Text | PDF | Amended Article

miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2

  • Text
  • PDF
Abstract

Authors

Enrique Fuentes-Mattei, Recep Bayraktar, Taghi Manshouri, Andreia M. Silva, Cristina Ivan, Diana Gulei, Linda Fabris, Nayra Soares do Amaral, Pilar Mur, Cristina Perez, Elizabeth Torres-Claudio, Mihnea P. Dragomir, Adriana Badillo-Perez, Erik Knutsen, Pranav Narayanan, Leonard Golfman, Masayoshi Shimizu, Xinna Zhang, Wanke Zhao, Wanting Tina Ho, Marcos Roberto Estecio, Geoffrey Bartholomeusz, Ciprian Tomuleasa, Ioana Berindan-Neagoe, Patrick A. Zweidler-McKay, Zeev Estrov, Zhizhuang J. Zhao, Srdan Verstovsek, George A. Calin, Roxana S. Redis

×

Single-cell transcriptomics reveals variations in monocytes and Tregs between gout flare and remission
Hanjie Yu, … , Ling Wang, Ai Peng
Hanjie Yu, … , Ling Wang, Ai Peng
Published February 8, 2024
Citation Information: JCI Insight. 2024;9(3):e179067. https://doi.org/10.1172/jci.insight.179067.
View: Text | PDF | Amended Article
Article has an altmetric score of 1

Single-cell transcriptomics reveals variations in monocytes and Tregs between gout flare and remission

  • Text
  • PDF
Abstract

Authors

Hanjie Yu, Wen Xue, Hanqing Yu, Yaxiang Song, Xinying Liu, Ling Qin, Shu Wang, Hui Bao, Hongchen Gu, Guangqi Chen, Dake Zhao, Yang Tu, Jiafen Cheng, Liya Wang, Zisheng Ai, Dayong Hu, Ling Wang, Ai Peng

×
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts

Picked up by 1 news outlets
Posted by 82 X users
7 readers on Mendeley
See more details
Picked up by 4 news outlets
Posted by 21 X users
46 readers on Mendeley
See more details
Posted by 2 X users
6 readers on Mendeley
See more details
Posted by 4 X users
11 readers on Mendeley
See more details
Posted by 3 X users
On 2 Facebook pages
4 readers on Mendeley
See more details
Posted by 3 X users
9 readers on Mendeley
See more details
Posted by 2 X users
Referenced in 1 Wikipedia pages
3 readers on Mendeley
See more details
Picked up by 4 news outlets
Posted by 3 X users
15 readers on Mendeley
See more details
Posted by 5 X users
40 readers on Mendeley
See more details
Posted by 3 X users
12 readers on Mendeley
See more details
Posted by 7 X users
4 readers on Mendeley
See more details
Posted by 1 X users
6 readers on Mendeley
See more details
Posted by 4 X users
7 readers on Mendeley
See more details
Posted by 3 X users
6 readers on Mendeley
See more details
Posted by 5 X users
On 1 Facebook pages
7 readers on Mendeley
See more details
Posted by 1 X users
16 readers on Mendeley
See more details
Posted by 1 X users
5 readers on Mendeley
See more details
Posted by 1 X users
20 readers on Mendeley
See more details
Posted by 5 X users
On 1 Facebook pages
3 readers on Mendeley
See more details
Posted by 5 X users
3 readers on Mendeley
See more details
Posted by 4 X users
14 readers on Mendeley
See more details
Posted by 13 X users
10 readers on Mendeley
See more details
Posted by 1 X users
7 readers on Mendeley
See more details
Posted by 1 X users
Referenced by 1 Bluesky users
See more details
Posted by 3 X users
6 readers on Mendeley
See more details
Posted by 6 X users
28 readers on Mendeley
See more details
Posted by 6 X users
Referenced by 1 Bluesky users
24 readers on Mendeley
See more details